 Previous work suggest that adiposity (mainly defined based on BMI) and depression are bidirectionally associated. However, BMI is an inaccurate measure of adiposity and does not distinguish between total body fat and visceral fat. Also, depression is a heterogeneous disease and patients can present themselves with a wide range of symptoms.
Introduction
Obesity and depression are serious health conditions that both constitute major economic and social burdens worldwide (1) . Although there is an abundance of research that examined the complex association between both conditions, the conclusions are inconsistent (2) . Where the larger body of evidence is leaning toward the presence of a link between obesity and major depressive disorder (MDD) (3) , there are studies that reported that both conditions are unrelated (4) or only reported the presence of an association in sub-groups, for example in women (5) .
A recent review (3) summarized the epidemiological evidence of the interconnection between obesity and MDD from large meta-analyses: overall, evidence suggests that obesity and depression are bidirectionally associated, with the presence of one increasing the risk of developing the other.
Nevertheless, several important aspects of the relationship between obesity and depression need to be clarified. First of all, the majority of previous work in this field define obesity according to body mass index (BMI=body weight in kg/(height in m 2 )) (6) . However, BMI is an approximation of total body fat and does not distinguish between high muscle or fat mass (7). Furthermore, BMI value does not inform us about the distribution of the fat in the body (7, 8) . This could be of importance, because it is known that especially abdominal adiposity is associated with inflammation, insulin resistance and metabolic syndrome (9) .
Depression is also a heterogeneous condition: patients with a diagnosis of the same depressive disorder may endorse very different symptoms. This heterogeneity may have contributed to the inconsistency and variability observed in the reported association between adiposity and J o u r n a l P r e -p r o o f depression. This association appears to be stronger in certain subgroups of patients. Emerging evidence suggests that the MDD link with obesity measures, and related metabolic and inflammatory dysregulations (i.e. high lipid and glucose levels, low HDL-cholesterol and high inflammation markers), is stronger for patients with a symptom profile often labeled as "atypical", including neurovegetative symptoms related to energy metabolism such as hyperphagia, hypersomnia, fatigability and physical exhaustion (10) . Results from the Netherlands Study Depression and Anxiety (NESDA) cohort showed for instance that among patients with Major Depressive Disorder (MDD) appetite upregulation and 'leaden paralysis' (described as the feeling of being physically weighted down) during an active depressive episode were the symptoms most strongly associated with BMI and obesity-related inflammatory (high C-reactive protein (CRP) and tumor necrosis-α (TN-α)) (11) and endocrine (high leptin) alterations (12) . Whether this link between obesity correlates and specific depressive symptoms exists also in the general population is unknown.
We set out to coherently interrogate the relationship between overall and abdominal adiposity and depressive mood and its individual symptoms in 6459 participants from a populationbased cohort (Netherlands Epidemiology of Obesity (NEO) study). Several measures of adiposity were examined, including overall (BMI and total body fat) and abdominal or central (waist circumference and visceral adipose tissue) adiposity. Among these measures, total body fat and visceral adipose tissue are accurate measures for overall and abdominal adiposity, respectively. Furthermore, we examined the specific associations between the measures of adiposity with 30 depression-related symptoms (assessed by Inventory Depressive Symptomatology-Self Report 30 questionnaire (IDS-SR30)).
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Methods

Study design and population
The Netherlands Epidemiology of Obesity (NEO) study is a population-based cohort study including 6671 men and women aged 45 to 65 years (13) Tesla MR system (Philips Medical Systems, Best, The Netherlands). At the level of the fifth lumbar vertebra, three transverse images each with a slice thickness of 10 mm were obtained during a breath hold. The fat depots were converted from the number of pixels to squared centimeters for all three slides, using in-house-developed software (MASS, Medis, the Netherlands). In the analysis, the average of the three slices was used (14).
Assessment of depressive mood
We asked all participants to complete the Dutch translation of the IDS-SR30 questionnaire, which assesses specific depressive symptoms during the last week and their severity. The IDS-SR30 rates (via a 4-level response system) the presence of a wide array of depressive symptoms, including core symptoms of major depressive episodes, melancholic (e.g., anhedonia, nonreactive mood, psychomotor retardation/agitation, appetite or weight decrease, early morning awakening, and selfoutlook) and atypical (e.g., mood reactivity, leaden paralysis (physical exhaustion), weight gain or increased appetite, hypersomnia, and interpersonal sensitivity) features, and commonly associated symptoms (e.g., irritability, anxiety, somatic complaints). The total score ranges from 0 to 84, with higher scores indicating higher severity.
We regarded the participants as having clinically relevant depressive mood when their IDS-SR30 total score was ≥ 14. Furthermore, we grouped the participant according to the clinically predefined severity cut-offs as follow: score ≤ 13 as "no depressive mood" status (n=4540, reference), 14-25 as "mild depressive mood" (n=1397), 26-38 as "moderate depressive mood" (n=428), 39-48 is "severe depressive mood" (n=68) and 49-84 is "very severe depressive mood" (n=26) (15) . For analysis J o u r n a l P r e -p r o o f purposes and due to the relatively small sample size in moderate, severe and very severe subcategories, they have been merged into "moderate to very severe".
Covariates
By a self-reported questionnaire, participants were asked to report their date of birth, ethnicity, educational level (as a proxy for the socioeconomic status), tobacco smoking status and alcohol consumption. Participants reported the frequency, duration and intensity of their physical activity during leisure time, which was expressed in metabolic equivalents of tasks in hours per week (16) .
Caloric intake (KJ/day) was estimated by a food frequency questionnaire (17) . For the antidepressants N06AA and N06A, participants were asked to bring all the medications that they have been using for the last month to the NEO study center. Then, all prescribed and self-medication were recorded by research nurses based on Anatomical Therapeutic Chemical Classification System (ATC).
Statistical analysis
In the NEO study, individuals with a BMI of 27 kg/m 2 or higher were oversampled. To correctly represent associations in the general population adjustments for the oversampling of individuals with high BMI were made (18) . This was done by weighting individuals towards the BMI distribution of participants from the Leiderdorp municipality (19), whose BMI distribution was similar to the BMI distribution of the general Dutch population. All results are based on weighted analyses. First, we examined the association between each measure of adiposity with the IDS-SR30
clinical groups using multinomial logistic regression models; the "no depressive mood" groups was set as the reference group. The first model was adjusted for age and sex; the second model was adjusted J o u r n a l P r e -p r o o f for age, sex, education level, tobacco smoking, alcohol consumption, physical activity, caloric intake, and ethnicity. Additionally, since abdominal adiposity is strongly related to overall adiposity (Table S 1), all abdominal adiposity analyses were adjusted for total body fat (20) . Subsequently, we repeated these analyses after excluding participants who were using N06AA and N06A antidepressants. Finally, we stratified our main analysis (i.e., the multinomial logistic regression between adiposity measures and depressive mood) by sex.
Second, we used logistic regression to examine the relationship between the overall and abdominal adiposity measurements and the 30 individual items from the IDS-SR30. For each item, the four-level answer system was dichotomized to code for low (reference: levels 0) versus medium-high (levels 1,2,3) symptoms. Likewise, this analyses were adjusted for age and sex in the first model, and the confounding factors in model 2. Additionally, in order to account for the average depressive symptoms severity, adjustment for the IDS-SR30 total score was done (model 3 and 4). Analyses that included abdominal adiposity were additionally adjusted for total body fat. All statistical analysis were performed with STATA statistical software (StataCorp, College Stations, Texas, USA), version 14.0).
Results
Baseline characteristics for all 6459 participants included in this analysis of NEO cohort are shown in 
Measures of adiposity and depressive mood
The percentage of participants with depressive mood in each quartile of adiposity measures are illustrated in Figure 1 . For all adiposity measures the proportion of individuals with mild and moderate to very severe depressive mood is largest in the highest adiposity measure quartile. Odds ratios (OR) and 95% confidence intervals from adjusted multinomial logistic regression for the association between overall and abdominal adiposity measures and the severity of the depressive mood are shown in Table 2 . Overall and abdominal adiposity measures were positively associated with mild and moderate to very severe depressive mood in a graded fashion, with higher ORs for the moderate to very severe depressive mood than mild depressive mood. In general, ORs of total body fat were relatively higher than those obtained from other adiposity measures. For example, increased total body fat was associated with mild and moderate to very severe depressive mood (OR: 1.59 (95% CI: respectively).
When we repeated the analyses of multinomial logistic regression between overall and abdominal adiposity and depressive mood categories after exclusion of participants who were using antidepressants (6.6%) for any reason, results did not materially change (Table S 2 ). We also excluded individuals with type 2 diabetes, cardiovascular disease and hypertension and the effect estimates again did not materially change (Table S 3 ). The sex-stratified analyses are shown in Table S 4. Overall, direction and strength of effect sizes were similar between sexes.
Body fat measurements and depressive mood symptoms
The logistic regression analysis results of overall and abdominal adiposity measures and the individual 30 items of IDS-SR30 are shown in Figure 2 and fully reported Table S 5. We found that overall and abdominal adiposity measurements were significantly associated with 27 (BMI), 26 (total body fat), 14 (waist circumference), and 2 (visceral adipose tissue) of the 30 depressive mood symptoms. We ranked the ORs of the fully adjusted model (i.e., model 2) of logistic regression of overall and abdominal measures and the individual items of IDS-SR30 from high to low (Table S 6 ). "Atypical"
neurovegetative symptoms, such as hyperphagia, low energy level and physical exhaustion were consistently among top ranked symptoms across different measures of adiposity. Symptoms of problems falling asleep and early morning awakening showed no association with adiposity measures.
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Discussion
This study examined the nature of the association between accurate measures of adiposity (i.e., total body fat and visceral adipose tissue) and depressive mood in a population-based study that consisted of 6459 middle-aged individuals. We found that especially total body fat, and to a lesser extent other measures of overall and abdominal adiposity, was positively associated with the depressive mood in a graded fashion; as the severity of obesity increases the severity depressive mood increases.
In this study, we were able to replicate the previously reported positive association between BMI and depressive mood (2, 3, 21) . However, the question remained whether this positive association is due to high body fat or high muscle mass. To answer this question, we investigated the association between total body fat as estimated by bio-impedance analysis and depressive mood.
Previous studies that investigated the association between total body fat and depression were small.
The presence of a positive association between total body fat and depression was observed only in women in a previous work that aimed to determine the sex-specific relationship between obesity and depression (n=67) (22) . In the current study, we were able to detect a positive association between total body fat and depressive mood both in men and women, which may imply that total body fat specifically plays a crucial role in relation to depression.
We also set out to examine whether abdominal adiposity contributes to the previously reported association between adiposity and depressive mood. Compiled evidence has indicated that waist circumference, which has been used as a proxy for visceral adiposity, is positively associated with depression (23) . Nonetheless, waist circumference does not discriminate between visceral adipose tissue and abdominal subcutaneous fat (23, 24) . A population-based study of well-functioning older participants (25) showed that depressive mood at baseline predicted an elevation of the visceral adipose tissue measured by the computed tomographic (CT) scanning after five years follow-up. In our analysis, we found a positive association between the measures of abdominal adiposity (both waist circumference and visceral adipose tissue) and depressive mood. Nonetheless, since abdominal adiposity can be an indicator for overall adiposity we adjusted the analysis for total body fat to J o u r n a l P r e -p r o o f estimate the specific association of abdominal fat. As it has been reported previously (24), we found that the association between visceral adipose tissue and depressive mood attenuated after taking into account the total body fat adjustment, which may indicate that total body fat is a large contributor to the association between adiposity and depression. Interestingly, we found that the pattern of the main results were similar when stratifying the analyses by sex. This suggests that, despite the established differences in adiposity and depression prevalence across sex, the association between adiposity and depressive mood is consistent in men and women.
Depressive mood is a heterogeneous condition (26) . It has previously been suggested (10, 27) that adiposity related immune-metabolic dysregulations such as abnormal glucose, triglyceride, Creactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis-α (TN-α) concentrations are mainly associated with "atypical" neurovegetative symptoms of depression (28) . Using data from the NESDA cohort (12) , it has been shown that among patients with a current diagnosis of MDD, higher leptin concentration in the blood (which directly associated with the adiposity level in the body) is associated with symptoms related to energy metabolism like hyperphagia, fatigability and physical exhaustion, independently from BMI. More recent evidence confirmed that the association between this phenotypic constellation, and adiposity and immuno-metabolic dysregulation markers (i.e. C-reactive protein (CRP) and leptin) extended down to the genetic level. Large collaborative genetic studies (29, 30) reported that subjects with a MDD diagnosis reporting hyperphagia or weight gain during the most severe depressive episode in their lifetime, carried a higher number of risk variants for immunometabolic traits such as obesity, C-reactive protein (CRP), leptin, and triglycerides dysregulation. In the present study, we demonstrated that both overall and abdominal adiposity were most strongly associated with the same cluster of depressive mood symptoms that relate to energy metabolism (i.e.
hyperphagia, low energy level, and increased physical exhaustion) in addition to the more typical symptoms of depressive mood.
Biologically, depression is associated with imbalances in either the hypothalamic-pituitaryadrenal (HPA) axis, the immune system (inflammation), or the regulation of the metabolic pathways.
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Since these physiological systems are also highly interconnected, it is a challenging process to look at each one of them individually (3, 31) . Accumulation of adipose tissue above the normal levels is associated with low-grade inflammation, insulin resistance (32), leptin resistance (33) , and imbalanced activity of the hypothalamic-pituitary-adrenal (HPA) axis (34) which are known to be directly or indirectly associated with depressive mood (35) . Previous studies suggested that the neuroendocrine signaling processes that regulate both mood and energy metabolism are strongly interconnected (36) .
Leptin hormone stimulates the proopiomelanocortin (POMC) neuron in the nucleus of the hypothalamus that activates the transcription of the melanocortin peptides (i.e. α, β, and γ MSH, and
Mc3r and Mc4r) (37) . These peptides have been suggested to be responsible for regulating energy intake and energy expenditure (38). Common forms of obesity are thought to be associated with leptin resistance in the brain, blunting its anorexigenic effect and consequently disinhibiting feeding and energy storage despite increasing circulating leptin (39) . An impact of leptin on depression has been suggested by research on animal models (40, 41) indicating antidepressant-like effects of leptin, although exact underlying mechanisms remain unknown. It has been proposed (42) that alterations of the leptin-melanocortin pathway may impair not only its anorexigenic effect, leading to obesity, but also its effect on mood regulation, potentially leading to the development of depression.
Furthermore, genome-wide association studies for both obesity and depression show an intersectional association between genes that show strong hits in both conditions, such as neural growth regulator 1 (NEGR1) and olfactomedin 4 (OLFM4). Noteworthy, these genes play a role in energy regulating mechanism by modulating the synaptic plasticity in brain areas essential for regulating both mood and appetite (3). We could hypothesize that the impairment of energy homeostasis systems may represent the link that mechanistically connect adiposity with depressive mood. This mechanism may act in two, non-mutually exclusive, ways: as common underlying factor influencing the liability to both depression and obesity, or as mediating mechanisms in causal relationships between the two conditions.
Several additional mechanisms may explain the association between adiposity and depressive mood, including social and behavioral factors such as social rejection, exclusion and/or stigma (43).
An agent-based approach to study the effect of social rejection on depression found that individuals with obesity are more vulnerable to develop depression when obesity is less common in their social networks (44) . It is also possible that behavioral factors that define depressive mood such as low motivation, low energy level, physical inactivity and overconsumption of energy-dense food disturb the body homeostasis and lead to an accumulation of adiposity (36) .
Some methodological aspects should be considered. The NEO study is a population-based study in which adiposity measures and depressive mood along with potential confounding factors where thoroughly phenotyped. However, the cross-sectional design of this study does not allow us to draw a conclusion about the directionality of associations. Second, although we adjusted for a large number of covariates in the models, based on the nature of observational studies, residual confounding may still be present. Third, the question of whether total body fat or abdominal fat is more important cannot be answered from this data. Fourth, the depressive mood was assessed only via the self-report IDS-SR30 that may introduce a misclassification of the participants with depressive mood. Nevertheless, this instruments has been extensively validated and used in previous research and the proportion of identified patients with depressive mood in the present study (~30%) is similar to the previous report in populations with obesity (45).
In conclusion, in this study we showed that in the general population overall and abdominal adiposity measures were positively associated with the depressive mood. This association encompasses almost all depressive symptoms but was strongest for a specific cluster of ''atypical'' neurovegetative depressive symptoms that indicate a deformity in the energy metabolism and homeostasis pathways. Our results suggests that the energy homeostasis dysfunction could connect the mechanisms responsible for developing both adiposity and depressive mood, either as a common cause or in a mediating role. Future longitudinal and experimental studies that exploit the available '- J o u r n a l P r e -p r o o f Normally distributed data shown as mean and standard deviation (SD), skewed distributed data shown as median (25 th ,75 th percentiles) and categorical data are shown as percentage. High education level: university or college education, while other education level: none, primary school or lower vocational education. IDS-SR30: Inventory of Depressive Symptomatology (self-report). BMI: body mass index. Number of individual with available data for each adiposity measures (BMI=6459, total body fat n=6428, waist circumference=6420, visceral adipose tissue n=2475). OR: odds ratio per standard deviation. IDS-SR30: Inventory of depressive symptomatology (selfreport). None: score (0-13). Mild: score (14-25). Moderate to very severe: . BMI: body mass index. For analysis purposes moderate, severe and very severe IDS-SR30 groups have been merged into (moderate to very severe). Model 1: adjusted for age and sex. Model 2: adjusted for age, sex, educational level, smoking, alcohol consumption, physical activity, caloric intake and ethnicity. Models for waist circumference and visceral adipose tissue were additionally adjusted for total body fat. Number of individual with available data for each adiposity measures (BMI=6459, total body fat n=6428, waist circumference=6420, visceral adipose tissue n=2475).
